Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Steroglass is an Italian private company that designs, manufactures, and sells scientific instruments, borosilicate glassware, analytical systems, consumables, and pilot-scale process equipment for laboratory and industrial use. The company serves chemical, biotechnological, pharmaceutical, biological/diagnostic, food, environmental, and oenological markets, with particular offerings in evaporation, reaction systems, fermentation, freeze-drying, liquid handling, water activity analysis, and enzymatic/colorimetric testing. In pharma and biotech, Steroglass positions itself as a supplier of instruments and glass solutions used in research, production, and quality control, including applications relevant to APIs, CDMOs, and biopharmaceutical workflows. It appears to be a commercial-stage tools-and-equipment business rather than a therapeutic drug developer, and its healthcare relevance comes from enabling laboratory, analytical, and manufacturing operations across pharma, biotech, and diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Steroglass.